The EU drug regulator will launch an investigation into Russia’s Covid-19 shot
The EU drug regulator will launch an investigation next week into whether clinical trials of Russia’s Sputnik V Covid-19 vaccine contravened ethical standards, and Japan’s national champion, Renesas Electronics, is being forced to diversify due to the pressures brought on by the chip industry. Plus, the FT’s Latin America editor, Michael Stott, explains how president Jair Bolsonaro lost his grip of Brazil.
EU regulator to probe ethical standards of Sputnik vaccine trials
Chip industry pressures spur Renesas to diversify
Brazil’s coronavirus nightmare: ‘Bolsonaro is more isolated than ever’
Nematodes the latest casualty of post-Brexit trade glitches
See acast.com/privacy for privacy and opt-out information.
A transcript for this podcast is currently unavailable, view our accessibility guide.
Get alerts on FT News Briefing when a new story is published